Zantac
Zantac - Basic Information
- GN: Ranitidine hydrochloride
- Con: Zollinger-ellison syndrome (gastrinoma)
- Cla: information not available
Indication of Zantac:
The use of Ranitidine is indicated in the following conditions: Peptic ulcer disease Gastro-oesophageal reflux disease HeartburnAction of Zantac:
Zantac belongs to a class of drugs called histamine receptor antagonists. Its active ingredient, Ranitidine, works by decreasing the amount of acid the stomach produces.Dose Advice of Zantac:
Peptic Ulcer Disease The initial recommended dose is 300 mg orally given as a single evening dose for 4–8 weeks or 50 mg intravenously or intramuscularly given every 6–8 hours. Maintenance dosing is 150–300 mg orally given as a single evening dose. Gastro-Oesophageal Reflux Disease 300 mg orally given as a single evening dose Prevention of stress ulcer The initial dose is 50 mg intravenously given slowly An intravenous infusion of 125–250 micrograms/kg/hour should be continued until risk factors for stress ulcer are removed Heartburn 150 mg orally twice a day for 4–8 weeks. Children 2–4 mg/kg orally twice daily up to a maximum dose of 300 mg a day. 1 mg/kg intravenously every 6–8 hours up to a maximum dose of 50 mg.Schedule of Zantac:
S4Common side effects of Zantac:
Headache Fatigue Dizziness Confusion (especially in elderly people) Diarrhoea Constipation RashUncommon side effects of Zantac:
Development of breast tissue in males Decreased libido Impotence Reversible involuntary movementDiseases treated by Zantac:
Zollinger-Ellison Syndrome (Gastrinoma)Symptoms associated with Zantac:
Heartburn Managing the Symptoms of GORDGN: Ranitidine hydrochloride
Con: Zollinger-Ellison Syndrome (Gastrinoma)